IRIS Registry data showed no change in anti-VEGF frequency, vision, or retinal thickness after patients with DME began a GLP-1RA.
Preeti Nagalamadaka, BS
Advertisement
Preeti Nagalamadaka, BS, is a third-year medical student at Brown University and a research intern at Harvard.
Articles by Preeti Nagalamadaka, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
One day, three approvals: FDA expands options for ocular redness, thyroid eye disease, and presbyopia
2
Duravyu misses wet AMD end point again as EyePoint pivots to DME
3
The Retina TL;DR with Dr. Weng: Thriving in fellowship with Amer Alsoudi, MD, and Monia Reding, MD
4
Brepocitinib meets all Phase 3 end points in noninfectious uveitis
5